Oak Hill Bio ("Oak Hill"), a clinical-stage neonatology and rare disease therapeutics company developing life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune
The presentation highlights the potential of OHB-607 to prevent bronchopulmonary dysplasia in extremely preterm neonates Oak Hill Bio ("Oak Hill"), a clinical-stage neonatology and rare disease therapeutics